FDA rejects MDMA for treating PTSD, calls for redo of study, drugmaker says

FDA rejects MDMA for treating PTSD, calls for redo of study, drugmaker says
Drugmaker Lykos Therapeutics had asked the FDA to approve its MDMA capsules as part of a therapy regimen for treating PTSD. It says another study will take "several years."
www.sentrypc.com